Profusa, Inc.

Profusa, Inc. (Nasdaq: PFSA) is a digital health and medical device company focused on implantable biosensor technology designed for continuous, real-time monitoring of body chemistry, including tissue oxygen levels. The company's flagship platform, the Lumee Oxygen System, targets clinical and consumer health applications within the broader biosensors and remote patient monitoring sector. Profusa filed a Form 10-Q with the SEC on August 14, 2023, under accession number 0001213900-23-067194, reflecting its status as an active reporting company. The filing covers operations during a period of continued commercial and regulatory development for the company's biosensor pipeline. Sign up at SpacDesk for full filings, deal history, and real-time analytics on Profusa and hundreds of other SPAC-linked companies.